(-)-alpha-phellandrene increases expression ISO RGD:1352703 6480464 alpha phellandrene results in increased expression of SLC44A1 mRNA CTD PMID:25075043 1,2-dichloroethane decreases expression ISO RGD:1557932 6480464 ethylene dichloride results in decreased expression of SLC44A1 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1557932 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC44A1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1557932 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC44A1 mRNA CTD PMID:22206623 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of SLC44A1 mRNA CTD PMID:21983209 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1352703 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1352703 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC44A1 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC44A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1557932 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC44A1 mRNA CTD PMID:26290441 2,4,6-tribromophenol increases expression ISO RGD:1352703 6480464 2 more ... CTD PMID:31675489 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SLC44A1 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:1352703 6480464 beta-methylcholine affects the expression of SLC44A1 mRNA CTD PMID:21179406 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1352703 6480464 tetrabromobisphenol A results in increased expression of SLC44A1 protein CTD PMID:31675489 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1352703 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SLC44A1 mRNA CTD PMID:28628672 3-methylcholanthrene multiple interactions ISO RGD:1352703 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to SLC44A1 promoter] CTD PMID:20348232 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC44A1 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC44A1 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1352703 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC44A1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC44A1 mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SLC44A1 mRNA CTD PMID:28959563 aflatoxin B1 decreases expression ISO RGD:1557932 6480464 Aflatoxin B1 results in decreased expression of SLC44A1 mRNA CTD PMID:19770486 all-trans-retinoic acid multiple interactions ISO RGD:1352703 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of SLC44A1 mRNA CTD PMID:15894607 all-trans-retinoic acid increases expression ISO RGD:1352703 6480464 Tretinoin results in increased expression of SLC44A1 mRNA CTD PMID:15894607 , PMID:33167477 alpha-phellandrene increases expression ISO RGD:1352703 6480464 alpha phellandrene results in increased expression of SLC44A1 mRNA CTD PMID:25075043 alpha-pinene multiple interactions ISO RGD:1352703 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC44A1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC44A1 mRNA CTD PMID:32699268 aristolochic acid A decreases expression ISO RGD:1352703 6480464 aristolochic acid I results in decreased expression of SLC44A1 mRNA CTD PMID:33212167 arsenous acid multiple interactions ISO RGD:1352703 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SLC44A1 mRNA CTD PMID:15894607 arsenous acid decreases expression ISO RGD:1352703 6480464 Arsenic Trioxide results in decreased expression of SLC44A1 mRNA CTD PMID:15761015 atrazine increases expression ISO RGD:1352703 6480464 Atrazine results in increased expression of SLC44A1 mRNA CTD PMID:22378314 benzo[a]pyrene multiple interactions ISO RGD:1557932 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to SLC44A1 promoter] CTD PMID:19654925 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1557932 6480464 Diethylhexyl Phthalate results in increased expression of SLC44A1 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1557932 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of SLC44A1 mRNA] CTD PMID:19850644 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC44A1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1352703 6480464 bisphenol A results in decreased expression of SLC44A1 protein CTD PMID:31675489 bisphenol A increases expression ISO RGD:1352703 6480464 bisphenol A results in increased expression of SLC44A1 mRNA CTD PMID:29275510 butan-1-ol multiple interactions ISO RGD:1352703 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC44A1 mRNA CTD PMID:29432896 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SLC44A1 mRNA CTD PMID:25993096 cadmium dichloride increases expression ISO RGD:1352703 6480464 Cadmium Chloride results in increased expression of SLC44A1 mRNA CTD PMID:26472689 calcitriol decreases expression ISO RGD:1352703 6480464 Calcitriol results in decreased expression of SLC44A1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1352703 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SLC44A1 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:1557932 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1557932 6480464 Nanotubes, Carbon results in decreased expression of SLC44A1 mRNA CTD PMID:25620056 clofibrate multiple interactions ISO RGD:1557932 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC44A1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC44A1 mRNA] CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1352703 6480464 cobaltous chloride results in decreased expression of SLC44A1 mRNA CTD PMID:19320972 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of SLC44A1 mRNA CTD PMID:24386269 cocaine affects expression EXP 6480464 Cocaine affects the expression of SLC44A1 mRNA CTD PMID:20187946 copper atom multiple interactions ISO RGD:1352703 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC44A1 mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:1352703 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC44A1 mRNA CTD PMID:24690739 copper(II) sulfate decreases expression ISO RGD:1352703 6480464 Copper Sulfate results in decreased expression of SLC44A1 mRNA CTD PMID:19549813 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SLC44A1 mRNA CTD PMID:26577399 , PMID:27523638 cyclosporin A increases expression ISO RGD:1352703 6480464 Cyclosporine results in increased expression of SLC44A1 mRNA CTD PMID:27989131 cyclosporin A decreases expression ISO RGD:1352703 6480464 Cyclosporine results in decreased expression of SLC44A1 mRNA CTD PMID:24907557 , PMID:25562108 decabromodiphenyl ether increases expression ISO RGD:1352703 6480464 decabromobiphenyl ether results in increased expression of SLC44A1 protein CTD PMID:31675489 dexamethasone increases expression ISO RGD:1557932 6480464 Dexamethasone results in increased expression of SLC44A1 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1352703 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SLC44A1 mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO RGD:1352703 6480464 Arsenic Trioxide results in decreased expression of SLC44A1 mRNA CTD PMID:15761015 diarsenic trioxide multiple interactions ISO RGD:1352703 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SLC44A1 mRNA CTD PMID:15894607 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SLC44A1 mRNA CTD PMID:21266533 disulfiram multiple interactions ISO RGD:1352703 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC44A1 mRNA CTD PMID:24690739 diuron increases expression EXP 6480464 Diuron results in increased expression of SLC44A1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1352703 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1352703 6480464 Doxorubicin results in decreased expression of SLC44A1 mRNA CTD PMID:29803840 ethanol multiple interactions ISO RGD:1352703 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC44A1 mRNA CTD PMID:29432896 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC44A1 mRNA CTD PMID:24136188 folic acid decreases expression ISO RGD:1557932 6480464 Folic Acid results in decreased expression of SLC44A1 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1557932 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC44A1 mRNA CTD PMID:22206623 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC44A1 mRNA CTD PMID:22061828 glafenine increases expression EXP 6480464 Glafenine results in increased expression of SLC44A1 mRNA CTD PMID:24136188 indometacin multiple interactions ISO RGD:1352703 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SLC44A1 mRNA CTD PMID:28628672 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of SLC44A1 mRNA CTD PMID:20097248 isobutanol multiple interactions ISO RGD:1352703 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC44A1 mRNA CTD PMID:29432896 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SLC44A1 mRNA CTD PMID:30467583 methylmercury chloride decreases expression ISO RGD:1352703 6480464 methylmercuric chloride results in decreased expression of SLC44A1 mRNA CTD PMID:23179753 , PMID:28001369 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC44A1 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLC44A1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1352703 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC44A1 mRNA more ... CTD PMID:32699268 paracetamol multiple interactions ISO RGD:1557932 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC44A1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC44A1 mRNA] CTD PMID:17585979 paracetamol affects expression ISO RGD:1557932 6480464 Acetaminophen affects the expression of SLC44A1 mRNA CTD PMID:17562736 pirinixic acid increases expression ISO RGD:1557932 6480464 pirinixic acid results in increased expression of SLC44A1 mRNA CTD PMID:18301758 more ... SB 431542 multiple interactions ISO RGD:1352703 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A1 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1352703 6480464 Silicon Dioxide analog results in decreased expression of SLC44A1 mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:1557932 6480464 Silver results in decreased expression of SLC44A1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1557932 6480464 Silver results in decreased expression of SLC44A1 mRNA CTD PMID:27131904 Soman increases expression EXP 6480464 Soman results in increased expression of SLC44A1 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1557932 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC44A1 mRNA CTD PMID:21641980 , PMID:23086747 testosterone decreases expression ISO RGD:1352703 6480464 Testosterone results in decreased expression of SLC44A1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1352703 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SLC44A1 mRNA CTD PMID:21592394 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC44A1 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1557932 6480464 Carbon Tetrachloride results in decreased expression of SLC44A1 mRNA CTD PMID:31919559 titanium dioxide decreases expression ISO RGD:1557932 6480464 titanium dioxide results in decreased expression of SLC44A1 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC44A1 mRNA CTD PMID:25729387 valproic acid affects expression ISO RGD:1557932 6480464 Valproic Acid affects the expression of SLC44A1 mRNA CTD PMID:17292431 , PMID:17963808 valproic acid decreases expression ISO RGD:1352703 6480464 Valproic Acid results in decreased expression of SLC44A1 mRNA CTD PMID:28001369 valproic acid increases expression ISO RGD:1352703 6480464 Valproic Acid results in increased expression of SLC44A1 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1352703 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A1 mRNA CTD PMID:27188386 valproic acid decreases methylation ISO RGD:1352703 6480464 Valproic Acid results in decreased methylation of SLC44A1 gene CTD PMID:29154799 vancomycin decreases expression ISO RGD:1557932 6480464 Vancomycin results in decreased expression of SLC44A1 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC44A1 mRNA CTD PMID:23034163
